Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000678

Type of data
NGS (WGS)
NGS (Exome)
NGS (RNA-seq)
NGS (ATAC-seq)
Methylation array
Access criteria
Controlled-access (Type I)
Total data volume
3.0 TB
File formats
  • FASTQ
  • IDAT
Research
hum0357
Date published
2022-11-02
Date modified
2023-02-15

Analysis method

WGS

Materials and participants
lung cancer (ICD10: C349): 22 cases
  • Health status
    Affected
  • Subject count
    22 (Individual)
Disease
lung cancer (C349)
Sample description
DNAs extracted from organoids established from tumor tissues
  • Tissue
    Organoid
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
WGS
Target
N/A
Reagent kit
SureSelect Human All Exon V6
Fragmentation
Ultrasonic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp

WES

Materials and participants
lung cancer (ICD10: C349)
[organoids]
21 cases
  • Health status
    Affected
  • Subject count
    95 (Individual)
Disease
lung cancer (C349)
Sample description
DNAs extracted from tumor tissues or organoids established from tumor or normal tissues
  • Tissue
    Organoid
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V6
Fragmentation
Ultrasonic fragmentation
Platform
Illumina HiSeq 2000
Read type
Paired-end
Read length
150 bp

RNA-seq

Materials and participants
lung cancer (ICD10: C349)
[organoids]
43 cases
  • Health status
    Mixed
  • Subject count
    113 (Individual)
Disease
lung cancer (C349)
Sample description
RNAs extracted from organoids established from tumor tissues
  • Tissue
    Organoid
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA Library Prep Kit
Fragmentation
TruSeq RNA Library Prep Kit v2
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp

ATAC-seq

Materials and participants
lung cancer (ICD10: C349)
[organoids]
42 cases
  • Health status
    Affected
  • Subject count
    83 (Individual)
Disease
lung cancer (C349)
Sample description
DNAs extracted from organoids established from tumor tissues
  • Tissue
    Organoid
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
ATAC-seq
Target
N/A
Reagent kit
Nextera XT DNA Library Prep Kit
Fragmentation
Tn5 transposase
Platform
Illumina HiSeq X
Read type
Paired-end
Read length
150 bp

メチル化アレイ

Materials and participants
lung cancer (ICD10: C349): 42 cases
  • Health status
    Affected
  • Subject count
    42 (Individual)
Disease
lung cancer (C349)
Sample description
DNAs extracted from organoids established from tumor tissues
  • Tissue
    Organoid
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Methylation array
Target
N/A
Platform
Illumina Infinium MethylationEPIC
Probe count
850,000